Tj. Bivalacqua et al., Analysis of vasodilator responses to novel nitric oxide donors in the hindquarters vascular bed of the cat, J CARDIO PH, 38(1), 2001, pp. 120-129
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Controlled release of nitric oxide (NO.) may be useful in the treatment of
a variety of vascular disorders. NO. donors of the diazeniumdiolate family
with different rates of spontaneous NO. release have been synthesized. In t
he current study responses to seven diazeniurndiolate NO. donors (DEA/NO.,
DETA/NO., OXI/NO., PIPERAZI/NO., PROLT/NO., SPER/NO., and SULFI/NO.) were i
nvestigated in the hindquarters vascular bed of the cat. Intravenous inject
ions of all NO. donors caused dose-dependent decreases in systemic arterial
pressure and the rank order of potency was SNP > DEA/NO. > PIPERAZI/NO. >
SPER/NO. > PROLI/NO. > OXI/NO., Injections of all NO. donors into the hindl
imb perfusion circuit caused dose-related decreases in hindquarters perfusi
on pressure that were similar to the order of potency in decreasing systemi
c arterial pressure. The rank order of the time required for the response t
o return to 50% of the maximal decrease in pressure (T-1/2) and total durat
ion of action of the NO. donors was SPER/NO. > PIPERAZI/NO. > DEA/NO. > OXV
NO. > DETA/NO. > PROLI/NO. > SULFI/NO.. After treatment with the NO. syntha
se inhibitor, N-omega-nitro-L-arginine methyl ester (100 mg/kg, i.v.), hind
limb vasodilator responses to the NO. donors were not significantly differe
nt, but vasodilator responses to acetylcholine were significantly reduced.
After treatment with zaprinast (2 mg/kg, i.v.), a type V cyclic 3 ', 5 ' -g
uanosine monophosphate-specific phosphodiesterase inhibitor, the duration o
f vasodilator responses to the NO. donors, as measured by T-1/2, was increa
sed significantly, whereas the duration of the response to the beta (2)-adr
energic receptor agonist albuterol was unchanged. These data suggest that d
iazeniumdiolate NO. donors are endothelium-independent, directly stimulate
soluble guanylate cyclase, and decrease vascular resistance by increasing c
yclic 3 ', 5 ' -guanosine monophosphate levels in the hindquarters vascular
bed of the cat.